255 related articles for article (PubMed ID: 15653648)
1. Dosimetry of internal emitters.
Sgouros G
J Nucl Med; 2005 Jan; 46 Suppl 1():18S-27S. PubMed ID: 15653648
[TBL] [Abstract][Full Text] [Related]
2. Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.
Pauwels S; Barone R; Walrand S; Borson-Chazot F; Valkema R; Kvols LK; Krenning EP; Jamar F
J Nucl Med; 2005 Jan; 46 Suppl 1():92S-8S. PubMed ID: 15653657
[TBL] [Abstract][Full Text] [Related]
3. Nuclear medicine dosimetry.
Stabin M
Phys Med Biol; 2006 Jul; 51(13):R187-202. PubMed ID: 16790903
[TBL] [Abstract][Full Text] [Related]
4. Dosimetry in Peptide radionuclide receptor therapy: a review.
Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
J Nucl Med; 2006 Sep; 47(9):1467-75. PubMed ID: 16954555
[TBL] [Abstract][Full Text] [Related]
5. S-factor calculations for mouse models using Monte-Carlo simulations.
Bitar A; Lisbona A; Bardiès M
Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):343-51. PubMed ID: 17538523
[TBL] [Abstract][Full Text] [Related]
6. Canine anatomic phantom for preclinical dosimetry in internal emitter therapy.
Padilla L; Lee C; Milner R; Shahlaee A; Bolch WE
J Nucl Med; 2008 Mar; 49(3):446-52. PubMed ID: 18287264
[TBL] [Abstract][Full Text] [Related]
7. New internal radiation dose and modeling software; FDA approves commercial MIRDOSE successor.
J Nucl Med; 2004 Nov; 45(11):26N, 28N. PubMed ID: 15584137
[No Abstract] [Full Text] [Related]
8. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides.
Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626
[TBL] [Abstract][Full Text] [Related]
9. Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies.
Stovall M; Weathers R; Kasper C; Smith SA; Travis L; Ron E; Kleinerman R
Radiat Res; 2006 Jul; 166(1 Pt 2):141-57. PubMed ID: 16808603
[TBL] [Abstract][Full Text] [Related]
10. Dosimetry of beta nuclide filled balloon catheter in endovascular brachytherapy.
Chen Y; Geng J; Tian J; Yin D; Chen S
Biomed Mater Eng; 2004; 14(3):337-9. PubMed ID: 15299246
[No Abstract] [Full Text] [Related]
11. Absorbed fractions in ellipsoidal volumes for beta(-) radionuclides employed in internal radiotherapy.
Amato E; Lizio D; Baldari S
Phys Med Biol; 2009 Jul; 54(13):4171-80. PubMed ID: 19521004
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
13. State of the art in nuclear medicine dose assessment.
Stabin MG; Brill AB
Semin Nucl Med; 2008 Sep; 38(5):308-20. PubMed ID: 18662553
[TBL] [Abstract][Full Text] [Related]
14. A filtering approach based on Gaussian-powerlaw convolutions for local PET verification of proton radiotherapy.
Parodi K; Bortfeld T
Phys Med Biol; 2006 Apr; 51(8):1991-2009. PubMed ID: 16585841
[TBL] [Abstract][Full Text] [Related]
15. Kinetic modeling in support of radionuclide dose assessment.
Vicini P; Brill AB; Stabin MG; Rescigno A
Semin Nucl Med; 2008 Sep; 38(5):335-46. PubMed ID: 18662555
[TBL] [Abstract][Full Text] [Related]
16. Overview of dosimetry for Systemic Targeted Radionuclide Therapy (STaRT).
Wessels BW; Syh JH; Meredith RF
Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S39-45. PubMed ID: 16979438
[TBL] [Abstract][Full Text] [Related]
17. Experimental verification of lung dose with radiochromic film: comparison with Monte Carlo simulations and commercially available treatment planning systems.
Paelinck L; Reynaert N; Thierens H; De Neve W; De Wagter C
Phys Med Biol; 2005 May; 50(9):2055-69. PubMed ID: 15843736
[TBL] [Abstract][Full Text] [Related]
18. An efficient framework for photon Monte Carlo treatment planning.
Fix MK; Manser P; Frei D; Volken W; Mini R; Born EJ
Phys Med Biol; 2007 Oct; 52(19):N425-37. PubMed ID: 17881793
[TBL] [Abstract][Full Text] [Related]
19. Absorbed fractions for alpha-particles in tissues of trabecular bone: considerations of marrow cellularity within the ICRP reference male.
Watchman CJ; Jokisch DW; Patton PW; Rajon DA; Sgouros G; Bolch WE
J Nucl Med; 2005 Jul; 46(7):1171-85. PubMed ID: 16000287
[TBL] [Abstract][Full Text] [Related]
20. MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.
Wessels BW; Konijnenberg MW; Dale RG; Breitz HB; Cremonesi M; Meredith RF; Green AJ; Bouchet LG; Brill AB; Bolch WE; Sgouros G; Thomas SR
J Nucl Med; 2008 Nov; 49(11):1884-99. PubMed ID: 18927342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
